Product
Help
Pricing
About
Jobs
Log in
Get started
Institution
Add to collection
AgelessRx (United States)
Homepage:
agelessrx.com
Alternate names:
Ageless RX,
AgelessRx
ROR:
050hkp415
OpenAlex ID:
I4405272947
Evaluation of off-label rapamycin use to promote healthspan in 333 adults
2023
·
Tammi L. Kaeberlein
, Alan S. Green
, et al.
·
GeroScience
·
66
PDF
Low-dose naltrexone and NAD+ for the treatment of patients with persistent fatigue symptoms after COVID-19
2024
·
Anar Isman
, Andy Nyquist
, et al.
·
Brain Behavior & Immunity - Health
·
52
Influence of rapamycin on safety and healthspan metrics after one year: PEARL trial results
2025
·
Girish Harinath
, Virginia Lee
, et al.
·
Aging
·
47
PDF
The bioavailability and blood levels of low-dose rapamycin for longevity in real-world cohorts of normative aging individuals
2025
·
Girish Harinath
, Virginia Lee
, et al.
·
GeroScience
·
11
PDF
Evaluation of off-label rapamycin use on oral health
2024
·
Johnny Hudson
, Tammi Kaeberlein
, et al.
·
GeroScience
·
11
PDF
The role of quality of life data as an endpoint for collecting real-world evidence within geroscience clinical trials
2024
·
Girish Harinath
, Sajad Zalzala
, et al.
·
Ageing Research Reviews
·
9
The efficacy and tolerability of intermittent prandial acarbose to reduce glucose spikes in healthy individuals
2023
·
A. Isman
, A. Nyquist
, et al.
·
Translational Medicine of Aging
·
7
Unexpected Increase in Bone Mineral Density With Rapamycin and Low-Dose Naltrexone: A Case Report of a 52-Year-Old Woman With Osteopenia
2025
·
Amy Britton
, Girish Harinath
, et al.
·
Cureus
·
1
PDF
Low-Dose Naltrexone as a Potential Healthspan-Enhancing Intervention in a Normative Aging Cohort: Changes in Quality of Life and Immune Health Metrics
2024
·
Girish Harinath
, Sajad Zalzala
, et al.
·
1
PDF
A Novel Approach to Boosting Glutathione via Iontophoresis
2021
·
Sajad Zalzala
·
Cureus
PDF
Show more works
View as search
Works count:
10
Citation count:
1,096
Year
Topic
Type
